#ACR21 Abs#0818: Starting biologics in moderate vs severe RA activity: ▶️ Moderate disease activity: more likely to reach LDA, remission ▶️ Severe disease: greater overall improvements, but less likely to reach remission https://t.co/9jBtN9wUGF @Rheumnow